An APOO Pseudogene on Chromosome 5q Is Associated With Low-Density Lipoprotein Cholesterol Levels

Area of Science:

• Genetics
• Molecular Biology
• Cardiovascular Research

Background:

• Elevated low-density lipoprotein cholesterol (LDL-C) is a primary risk factor for cardiovascular disease.
• Known genetic variants explain only about 20% of LDL-C level variations.
• Identifying novel genetic contributors to LDL-C is crucial for understanding lipid homeostasis.

Purpose of the Study:

• To identify the causal gene responsible for LDL-C level variations.
• To investigate the role of a newly identified genetic variant in cholesterol metabolism.
• To elucidate a novel mechanism regulating lipid homeostasis.

Main Methods:

• Array-based association analysis in 1102 Amish subjects.
• Genetic analyses, including recombination mapping.
• Zebrafish models and in vitro experiments to assess gene function.

Main Results:

• A founder haplotype associated with a 15 mg/dL increase in LDL-C was identified on chromosome 5.
• Expression of the transcribed pseudogene APOOP1 in zebrafish models increased LDL-C and vascular plaque formation.
• APOOP1 was identified as a strong candidate gene within the associated region.

Conclusions:

• APOOP1 is proposed to regulate human LDL-C levels.
• This finding identifies a novel mechanism in lipid homeostasis.
• APOOP1 represents a potential new target for managing cardiovascular disease risk.